PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Immunoregulation and Vaccine Research, Tsukuba Primate Research Center.\', \'Laboratory of Biopharmaceutical Research, and.\', \'Laboratory of Antibody Design, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Japan.\', \'Global Center for Medical Engineering and Informatics, Osaka University, Suita, Japan.\', \'Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.\', \'Department of Biochemistry and Metabolic Science, Graduate School of Medicine, Akita University, Akita, Japan.\', \'Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, USA.\', \'Institute of Medical Science, University of Tokyo, Tokyo, Japan.\', \'National Center for Global Health and Medicine, Tokyo, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1172/jci.insight.152529e152529
?:doi
?:hasPublicationType
?:journal
  • JCI insight
is ?:pmid of
?:pmid
?:pmid
  • 34463644
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2-transgenic mice.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all